Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 24, 2013 - Issue 2
Submit an article Journal homepage
2,869
Views
11
CrossRef citations to date
0
Altmetric
Acne

Isotretinoin modestly increases platelet count in acne patients

Ayse Serap KaradagDepartment of Dermatology, Yuzuncu Yil University, Faculty of Medicine, Van, TurkeyCorrespondence[email protected]
,
Derun Taner ErtugrulDepartment of Internal Medicine, Division of Endocrinology and Metabolism, Ankara Kecioren Research and Training Hospital, Ankara, Turkey
&
Zennure TakciDepartment of Dermatology, Ankara Kecioren Research and Training Hospital, Ankara, Turkey
Pages 139-140 | Received 20 Aug 2011, Accepted 28 Aug 2011, Published online: 25 Oct 2011

References

  • Brelsford M, Beute TC. Preventing and managing the side effects of isotretinoin. Semin Cutan Med Surg. 2008;27:197–206.
  • Thielitz A, Krautheim A, Gollnick H. Update in retinoid therapy of acne. Dermatol Ther. 2006;19:272–279.
  • Charakida A, Mouser PE, Chu AC. Safety and side effects of the acne drug, oral isotretinoin. Expert Opin Drug Saf. 2004;3:119–129.
  • Ertam I, Alper S, Unal I. Is it necessary to have routine blood tests in patients treated with isotretinoin? J Dermatolog Treat. 2006;17:214–216.
  • Schweinfurth N, Hohmann S, Deuschle M, Lederbogen F, Schloss P. Valproic acid[c1] and all trans retinoic acid differentially induce megakaryopoiesis and platelet-like particle formation from the megakaryoblastic cell line MEG-01. Platelets. 2010;21:648–657.
  • Yu C, Liu Y, Miao Z, Yin M, Lu W, Lv Y, Retinoic acid enhances the generation of hematopoietic progenitors from human embryonic stem cell-derived hemato-vascular precursors. Blood. 2010;116:4786–4794.
  • Ganser A, Seipelt G, Verbeek W, Ottmann OG, Maurer A, Kolbe K, Effect of combination therapy with all-trans-retinoic acid and recombinant human granulocyte colony-stimulating factor in patients with myelodysplastic syndromes. Leukemia. 1994;8:369–375.
  • Gold EJ, Mertelsmann RH, Itri LM, Gee T, Arlin Z, Kempin S, Phase I clinical trial of 13-cis-retinoic acid in myelodysplastic syndromes. Cancer Treat Rep. 1983;67:981–986.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.